Diagnostic procedures definition

Diagnostic procedures means audiometric and medical procedures required to diagnose an infant as deaf or hard of hearing.
Sample 1Sample 2
Diagnostic procedures means audiometric and medical procedures required to diagnose hearing loss.
Sample 1Sample 2
Diagnostic procedures. Enabled Customer," "End User," "GAAP," "Gene Expression Field," "Genotyping Field," "Intellectual Property Rights," "InvaderCreator Access Agreement," "Invader Reaction," "Licensed Product," "Multiplexed Invader Application," "Patents," "Probe Set," and "Target," shall have the meaning given to the particular term in the License Agreement.
Sample 1

Examples of Diagnostic procedures in a sentence

  • From time to time ACLA and TWTI agree to discuss the possibility of cooperating with each other with respect to the combination of ACLA's proprietary eTag technology and TWTI's proprietary Invader technology for certain commercial applications including for applications in the Genotyping Field and for Diagnostic Procedures.

  • The efforts described in the Diagnostic Procedures document have led to a conclusion that the problem report is valid.

  • Interference Diagnostic Procedures..................................................................

  • The Plan provides benefits only in the form of payments to or on behalf of a Participant to pay or to reimburse all or part of the covered Medical Diagnostic Procedures of the Participant.

  • HealthGate will provide private label access for clients of EPIC to the following content sources and/or services: MEDLINE, AIDSLINE, AIDSDRUGS, AIDSTRIALS, HealthSTAR, Medical Software Reviews, DPH: Diagnostic Procedures, DIH: Drug Information (or US Pharmacopoeia), EMBASE Cardiology Consultant, Reuters Medical News, BIOETHICSLINE, CANCERLIT, Healthy Eating, Healthy Man, Healthy Woman, Healthy Sexuality, Healthy Parenting, Wellness Center family, Detwiler Directory, MDX Health Digest, and AgeLine.

  • If an Eligible Executive receives any procedures that are not Medical Diagnostic Procedures during an annual exam, those expenses will not be paid by the Plan.

  • The Plan does not provide payment or reimbursement for transportation expenses incurred in connection with allowable Medical Diagnostic Procedures.

  • Transportation Expenses are expenses incurred primarily to travel to a facility to receive Medical Diagnostic Procedures, but only to the extent they are ordinary and necessary.

  • Medical Diagnostic Procedures must be performed at a facility that provides no services (directly or indirectly) other than medical and ancillary services.

  • Each of the terms "Cleavage Enzyme," "Cleavase Enzyme," "Confidential Information," "Development and Commercialization Agreement," "Diagnostic Procedures," "Enabled Customer," "End User," "GAAP," "Gene Expression Field," "Genotyping Field," "Intellectual Property Rights," "InvaderCreator Access Agreement," "Invader Reaction," "Licensed Product," "Multiplexed Invader Application," "Patents," "Probe Set," and "Target," shall have the meaning given to the particular term in the License Agreement.

Related to Diagnostic procedures

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • AML/KYC Procedures means the customer due diligence procedures of a Reporting Finnish Financial Institution pursuant to the anti-money laundering or similar requirements of Finland to which such Reporting Finnish Financial Institution is subject.

  • Staff Vetting Procedures means the Authority’s procedures for the vetting of personnel and as advised to the Contractor by the Authority.

  • Diagnostic x-ray system means an x-ray system designed for irradiation of any part of the human or animal body for the purpose of diagnosis or visualization.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Staff Vetting Procedure means the Authority’s procedures for the vetting of personnel and as advised to the Contractor by the Authority.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Diagnosis of autism spectrum disorders means assessments, evaluations, or tests, including the autism diagnostic observation schedule, performed by a licensed physician or a licensed psychologist to diagnose whether an individual has 1 of the autism spectrum disorders.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Diagnosis of autism spectrum disorder means medically necessary assessments, evaluations, or tests

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.